56 related articles for article (PubMed ID: 2069116)
1. [Clinical studies and morphological response on ST-95 (fosfomycin)].
Washida H; Watanabe H; Noguchi Y; Kato M; Tozawa K; Inuzuka K
Hinyokika Kiyo; 1991 Mar; 37(3):321-6. PubMed ID: 2069116
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection.
Stein GE
Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258
[TBL] [Abstract][Full Text] [Related]
3. [Morphological response of urinary bacteria to ceftibuten].
Washida H; Sakagami H; Awata S; Kan K; Kawai N; Inuzuka K
Jpn J Antibiot; 1996 Mar; 49(3):273-8. PubMed ID: 8935123
[TBL] [Abstract][Full Text] [Related]
4. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
5. Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.
Gismondo MR; Romeo MA; Lo Bue AM; Chisari G; Nicoletti G
Chemioterapia; 1986 Aug; 5(4):278-82. PubMed ID: 3094965
[TBL] [Abstract][Full Text] [Related]
6. In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens.
Rossi L; Fontana R; Meloni GA
Chemioterapia; 1988 Feb; 7(1):10-4. PubMed ID: 3259908
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
[TBL] [Abstract][Full Text] [Related]
8. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
Ruxer J; Mozdzan M; Loba J; Markuszewski L
Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
[TBL] [Abstract][Full Text] [Related]
9. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
10. Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid.
Careddu P; Borzani M; Scotti L; Varotto F; Garlaschi L; Fontana P
Chemioterapia; 1987 Aug; 6(4):290-4. PubMed ID: 3652281
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience with fosfomycin in urinary tract infections (author's transl)].
Peters HJ; Eicher R
MMW Munch Med Wochenschr; 1981 May; 123(18):748-50. PubMed ID: 6785627
[TBL] [Abstract][Full Text] [Related]
13. Single-dose treatment of lower urinary tract infections with fosfomycin trometamol: preliminary experiences.
Arione R; Fontana P
Chemioterapia; 1987 Aug; 6(4):295-8. PubMed ID: 3308148
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on combination chemotherapy with fosfomycin and dibekacin in complicated urinary tract infection].
Amano M; Okunobo T; Ueda H; Ura H; Sone A; Furukawa Y; Saito N; Tanaka H
Hinyokika Kiyo; 1983 Aug; 29(8):947-52. PubMed ID: 6675445
[TBL] [Abstract][Full Text] [Related]
15. [Clinical observation of bacterial isolates from urine specimens of outpatients].
Doi T; Takeda A; Okano M; Fujihiro S; Hatano K; Kato N; Kanematsu M; Ban Y
Hinyokika Kiyo; 1987 Dec; 33(12):1979-87. PubMed ID: 3448922
[TBL] [Abstract][Full Text] [Related]
16. Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial.
Novelli A; Rizzo M; Buzzoni P; Coronnello M; Alunno Pergentini S; Giganti E; Periti P
Chemioterapia; 1984 Oct; 3(5):281-5. PubMed ID: 6398125
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of urinary tract infections in transurethral surgery].
Muramatsu H; Kariba T; Hata R; Amemiya H; Kiriyama I; Ueno M; Satoh H; Tsuchida H; Kumagai K; Iizumi T
Hinyokika Kiyo; 1987 Oct; 33(10):1708-11. PubMed ID: 3445855
[TBL] [Abstract][Full Text] [Related]
18. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
19. Urinary tract infections in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates.
Grude N; Tveten Y; Kristiansen BE
Clin Microbiol Infect; 2001 Oct; 7(10):543-7. PubMed ID: 11683794
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience of norfloxacin in urinary tract infection].
Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
